Natixis Investment Managers International’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-63,358
Closed -$859K 21
2018
Q3
$859K Sell
63,358
-42,119
-40% -$571K 0.04% 368
2018
Q2
$1.25M Buy
+105,477
New +$1.25M 0.07% 220